Long-form essays examining the scientific claims and limits of biological research, especially organoids in drug discovery, disease modeling, and Alzheimer's research. Readers get critical, detailed analysis of where lab models succeed, fail, and get overhyped, plus updates from the author's work on AI and health.

A retired cardiologist and former FDA official documents his personal effort to find a Parkinson's treatment, mixing commentary on recent trial results with his own research history and operational updates on drug development. Readers get a firsthand, detailed view of how a non-specialist approaches PD science and what regulatory and safety steps a potential drug must clear.

A neuroscience-focused newsletter by Dr. Sydney Ceruto explaining how the brain forms habitual decisions, emotional patterns, and reactions, with rat experiments and brain-region explanations. Each issue offers a single reflective question or practical reframe the reader can apply to everyday situations.

William Wallace, Ph.D. investigates the biochemistry behind health claims, checking each claim in an episode against the cited studies and marking whether the evidence is observational, animal-only, or untested in people. Recent issues cover nicotine and Parkinson's disease, whether microplastics accumulate in the brain, and the origins and evidence for the peptide BPC-157.